A year-end review of some of the new cancer treatments, exciting breakthroughs, and insights into cancer's development that emerged...
The AACR Annual Meeting 2018 drew more than 22,600 people to Chicago, providing a front-row seat to some exciting...
A study presented at the AACR Annual Meeting 2018 discussed preliminary data on an off-the-shelf, T-cell receptor (TCR)-less, dual-targeted...
Early this week, the U.S. Food and Drug Administration (FDA) approved a combination immunotherapy regimen for treating certain patients...
This post originally appeared on the Cancer Today website. Roads and roadblocks, both literal and metaphorical, figured into a...
An exciting area in drug development, immunotherapy is being increasingly utilized by patients with different cancer types. These treatments...
Monday ushered in a ray of hope and promise for the lung cancer community at the AACR Annual Meeting...
This post originally appeared on the Cancer Today website. “This is a historic time in cancer research,” said Elizabeth...
As the 2018 Annual Meeting of the American Association for Cancer Research unfolded yesterday morning, the excitement among the...
Two graduates of the AACR Scientist↔Survivor Program, a special educational experience that gives patient advocates the opportunity to attend...
The AACR’s Pediatric Cancer Working Group, which now boasts over 2,500 members, will hold a special scientific session at...